Case Western Reserve University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Case Western Reserve University sits in the top decile of US sponsors by registered trial count (#198 of 15,742 sponsors by registered trial count).
Case Western Reserve University: 141 sponsored US clinical trials, 23 recruiting.
Case Western Reserve University sponsors 141 registered US clinical trials on ClinicalTrials.gov, 23 of them currently recruiting, and 100 completed. 6 of these trials are in Phase 3-4 (later-stage) and 10 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Bipolar Disorder, with 6 trials.
Top-decile sponsor footprint
Case Western Reserve University ranks in the top decile of sponsors by registered trial count (#198 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
100 of 103 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (97.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
141 total, page 3 of 3
Wheezing in Black Preterm Infants: Impact of Vitamin D Supplementation Strategy
NCT01601847
Health Promotion and Wellness Program for Adults With Disabling Conditions
NCT01776034
Patient and Physician Intervention to Increase Organ Donation
NCT01697137
Targeted Management Intervention for African-American Men With TIA or Stroke
NCT01807793
Cornea Preservation Time Study
NCT01537393
Treatment Adherence Enhancement in Bipolar Disorder
NCT01542008
Nonvisual Foot Examination for People With Diabetes and Visual Impairment
NCT02102958
Promoting Physical Activity Behavior in Persons With Multiple Sclerosis
NCT01572207
Improving Outcomes for Individuals With Serious Mental Illness and Diabetes
NCT01410357
Examining the Effects of a Telehealth Self-management Intervention in Multiple Sclerosis
NCT01572714
Optimizing Posttraumatic Stress Disorder Treatment: Prolonged Exposure (PE) Versus PE Plus Sertraline
NCT01600456
Ideas Moving Parents and Adolescents to Change Together (IMPACT)
NCT01514279
Electronic Self-management Resource Training for Mental Health
NCT01304862
Study of SystemCHANGE-HIV
NCT01256814
Cancer Prevention and Care Among Aged
NCT01831375
Use of Sterile Water Feeds for Treatment of Hypernatremia in Extremely Low Birth Weight Infants
NCT01219179
Nonvisual Foot Inspection for People With Visual Impairment
NCT01822717
Enhancing Teachable Moment Communication for Smoking Cessation and Weight Management
NCT01575886
Lactobacillus Reuteri in the Prevention of Antibiotic Associated-diarrhea and Clostridium Difficile
NCT02127814
Interstitial Cystitis: Elucidation of the Psychophysiologic and Autonomic Characteristics (ICEPAC) Study
NCT01616992
Dose of Early Therapeutic Mobility: Does Type or Frequency Matter?
NCT00999011
Community Trial to Enhance Organ Donation
NCT00870506
Transplant Navigator Intervention to Overcome Barriers to Kidney Transplantation
NCT00805038
A Trial of Vitamin D Therapy in Patients With Heart Failure
NCT01125436
Customized Medication Adherence Enhancement for Treating Adults With Bipolar Disorder
NCT00763919
Personal Adherence Evaluation of Medication Use for Adult Bipolar Disorder Patients
NCT00763581
Portable Monitoring for Diagnosis and Management of Sleep Apnea
NCT00642486
Xylitol for Caries Prevention in Inner-City Children
NCT01901250
Analyzing Genes That May Increase the Risk of Developing High Blood Pressure
NCT00549991
Pentoxifylline in Patients With Nonalcoholic Steatohepatitis
NCT00590161
Efficacy of Continuous Positive Airway Pressure in Reducing Oxidative Stress in Individuals With Sleep Apnea
NCT00607893
Safety and Efficacy of Autologous, Intracoronary Stem Cell Injections in Total Coronary Artery Occlusions
NCT00365326
Intensive Communication for Chronically Critically Ill
NCT01057238
Cross-over Comparison of Gabapentin and Memantine as Treatment for Acquired Nystagmus
NCT00928954
Comparison of Two Treatments for Post-Traumatic Stress Disorder
NCT00127673
Understanding Treatment Adherence Among Individuals With Rapid Cycling Bipolar Disorder
NCT00183703
Understanding Treatment Adherence Among Individuals With Bipolar Disorder
NCT00183495
Kangaroo Care and Premature Infant Sleep
NCT02473055
Enhancing Treatment Adherence in Pediatric Asthma With a Problem Solving Intervention
NCT00149487
Abbreviated MgSO4 Therapy in Post-partum Preeclampsia
NCT00344058
Study of an Implantable Functional Neuromuscular Stimulation System for Patients With Spinal Cord Injuries
NCT00004445
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 6 |
| Phase 2 | 4 |
| Phase 3 | 2 |
| Phase 4 | 4 |
Therapeutic Areas
What is open in the Case Western Reserve University pipeline
23 recruiting of 141 indexed (16% open); 100 completed (71%).
Phase mix: 6 late (III/IV) vs 10 early (I/II) (early-phase heavy).
Top condition: Bipolar Disorder (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Case Western Reserve University: open-pipeline peers nationwide
Peers matched on 141 registered trials and 16% open enrollment, not the therapeutic-area sidebar.
Case Western Reserve University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 141 trials (± recruiting share)
- Eastern Cooperative Oncology Group · 141 trials · 3% recruiting
- Purdue University · 141 trials · 10% recruiting
- Johnson & Johnson Vision Care · 142 trials · 1% recruiting
- Mclean Hospital · 140 trials · 19% recruiting
Sponsors near 16% open enrollment (± trial volume)
- Drexel University · 16% recruiting · 92 trials
- H. Lee Moffitt Cancer Center and Research Institute · 16% recruiting · 502 trials
- Atlantic Health System · 16% recruiting · 43 trials
- BioMarin Pharmaceutical · 16% recruiting · 80 trials
Related
What to do with this Case Western Reserve University page
141 registered trials is a research-attention snapshot, not an endorsement of Case Western Reserve University or any single study.
- 23 of Case Western Reserve University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Bipolar Disorder is the condition Case Western Reserve University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Bipolar Disorder trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Case Western Reserve University pipeline card: 141 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.